Cervical cancer screening: Women's knowledge, attitudes, and practices in the region of Monastir (Tunisia)

Revue d'Epidemiologie et de Sante Publique

Volumn 60, Issue 6, 2012, Pages 431-436

  El Mhamdi, S ^a   Bouanene, I ^a   Mhirsi, A ^b   Bouden, W ^a   Soussi Soltani, M ^a  

^a UNIVERSITY OF MONASTIR   (Tunisia)

^b Direction of Primary Health Care   (Tunisia)

Author keywords

Attitudes; Early detection of cancer; Health knowledge; Practices; Tunisia; Uterine cervical neoplasms

Indexed keywords

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; ATTITUDE TO HEALTH; CANCER SCREENING; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; EDUCATION PROGRAM; EDUCATIONAL STATUS; FEMALE; HEALTH CARE PRACTICE; HEALTH CENTER; HEALTH EDUCATION; HEALTH PROGRAM; HUMAN; KNOWLEDGE; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; RISK FACTOR; STRUCTURED QUESTIONNAIRE; TUNISIA; UTERINE CERVIX CANCER; WOMEN'S HEALTH;

ADULT; CROSS-SECTIONAL STUDIES; EARLY DETECTION OF CANCER; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MIDDLE AGED; QUESTIONNAIRES; RISK FACTORS; TUNISIA; UTERINE CERVICAL NEOPLASMS; WOMEN'S HEALTH;

EID: 84870717057     PISSN: 03987620     EISSN: 17730627     Source Type: Journal    
DOI: 10.1016/j.respe.2012.03.009     Document Type: Article

References (32)

1. Pointreau Y., Ruffier Loubière A., Denis F., Barillot I. Cancer du col utérin. Cancer Radiother 2010, 14:S147-S153.
2. Kim J.J., Brisson M., Edmunds W.J., Goldie S.J. Modeling cervical cancer prevention in developed countries. Vaccine 2008, 26(Suppl. 10):K76-K86.
3. Erbil N., Tezcan Y., Gür E.N., Yi{dotless}ldi{dotless}ri{dotless}m M., Ali{dotless}ş N. Factors affecting cervical screening among Turkish women. Asian Pac J Cancer Prev 2010, 11:1641-1644.
4. Ministry of health. Direction of primary health care. Annual health care report (2008).
5. Maalej M., Mrad K., Kochbati L., Guigua A., Ben Abdallah M., Ben Ayed F., et al. Cervical cancer in Tunisia: an epidemiological, clinical and pathological study. Eur J Obstet Gynecol Reprod Biol 2004, 113(2):226-228.
6. Republic of Tunisia. Tunisian association against cancer. Progress report 1987-1990 (consulted on 17/12/2011). http://www.atcc.org.tn/factions.htm.
7. Ben Aissa R., Bennour R., Ben Hamida A., Kammoun N., Mansour H., Mhamdi A., et al. Cervical cancer screening by Pap smear: experience of the National Research Center in Reproductive Health. ONFP. Tunis Med 2002, 80(4):203-206.
8. Sethom F., Besbes K., Cammoun M. For an early diagnosis of cervical cancer by systematic vaginal smears--clinical and psychological approach. Tunis Med 1989, 67(8-9):505-511.
9. Ministère de la Santé publique. Direction des soins de santé de base. Rapport annuel 2008.
10. Hsairi M., Fakfakh R., Bellaaj R., Achour N. Recours au dépistage du cancer du col utérin chez les femmes résidentes dans deux régions du Nord de la Tunisie. Tunis Med 2003, 81:721-730.
11. Tiro J.A., Meissner H.I., Kobrin S., Chollette V. What do women in the U.S. know about human papillomavirus and cervical cancer?. Cancer Epidemiol Biomarkers Prev 2007, 16:288-294.
12. Missaoui N., Trabelsi A., Landolsi H., Jaidaine L., Mokni M., Korbi S., et al. Cervical adenocarcinoma and squamous cell carcinoma incidence trends among Tunisian women. Asian Pac J Cancer Prev 2010, 11(3):777-780.
13. Maalej M., Daoud J., Messaad J., Frikha H., Benna F., Hechiche M., et al. Le cancer invasif du col utérin chez la femme jeune en Tunisie. Bull Cancer Radiother 1996, 83(3):158-163.
14. Republic of Tunisia. National Institute of Statistics. Tunisian population and housing Census (2004). http://www.ins.nat.tn/indexfr.php (Consulted the 19/12/2011).
15. Cronjé H.S. Screening for cervical cancer in the developing world. Best Pract Res clin Obstet Gynaecol 2005, 19(4):517-529.
16. Al-Naggar R.A., Low W.Y., Isa Z.M. Knowledge and barriers towards cervical cancer screening among young women in Malaysia. Asian Pac J Cancer Prev 2010, 11(4):867-873.
17. Hogue M., Hogue E., Kader S.B. Evaluation of cervical cancer screening program at a rural community of South Africa. East Afr J Public Health 2008, 5(2):111-116.
18. Amarin Z.O., Badria L.F., Obeidat B.R. Attitudes and beliefs about cervical smear testing in ever-married Jordanian women. East Mediterr Health J 2008, 14(2):389-397.
19. Cuzick J., Arbyn M., Sankaranarayanan R., et al. Overview of human papillomavirus-based and other novel options for cervical cancer screening in developed and developing countries. Vaccine 2008, 19; 26(Suppl. 10):K29-K41.
20. Ackerson K., Pohl J., Low L.K. Personal influencing factors associated with pap smear testing and cervical cancer. Policy Polit Nurs Pract 2008, 9(1):50-60.
21. Watts S. Access to cervical screening for women with learning disabilities. Br J Nurs 2008, 17(8):518-525.
22. Baay M.F., Verhoeven V., Peremans L., Avonts D., Vermorken J.B. General practitioners' perception of risk factors for cervical cancer development: consequences for patient education. Patient Educ Couns 2006, 62(2):277-281.
23. Paolino M., Arrossi S. Women's knowledge about cervical cancer. Pap smear and human papillomavirus and its relation to screening in Argentina. Women Health 2011, 51(1):72-87.
24. Ho V., Yamal J.M., Atkinson E.N., Basen-Engguist K., Tortolero-Luna G., Follen M. Predictors of breast and cervical screening in Vietnamese women in Harris County, Houston, Texas. Cancer Nurs 2005, 28(2):119-129.
25. Ackerson K., Gretebeck K. Factors influencing cancer screening practices of underserved women. J Am Acad Nurse Pract 2007, 19(11):591-601.
26. Chan Chee C., Begassat M., Kovess V. Les facteurs associés au dépistage des cancers du col utérin dans une population mutualiste. Rev Epidemiol Sante Publ 2005, 53(1):69-75.
27. Johnson C.E., Mues K.E., Mayne S.L., Kiblawi A.N. Cervical cancer screening among immigrants and ethnic minorities: a systematic review using the Health Belief Model. J Low Genit Trac Dis 2008, 12(3):232-241.
28. Tacken M.A., Braspenning J.C., Hermens R.P., Spreeuwenberg P.M., van den Hoogen H.J., De Bakker D.H. Uptake of cervical cancer screening in the Netherlands is mainly influenced by women's beliefs about the screening and by the inviting organization. Eur J Public Health 2007, 17(2):178-185.
29. Krennhrubec K., Mrad K., Sriha B., Ben Ayed F., Bottalico D.M., Ostolaza J., et al. HPV types and variants among cervical cancer tumors in three regions of Tunisia. J Med Virol 2011, 83(4):651-657.
30. Alhamany Z., El Mzibri M., Kharbach A., Malihy A., Abouqal R., Jaddi H., et al. Prevalence of human papillomavirus genotype among Moroccan women during a local screening program. J Infect Dev Ctries 2010, 4(11):732-739.
31. Abd ElAzim S., Lotfi M., Omr A. Detection of human papillomavirus genotypes in cervical intraepithelial neoplasia and invasivecancer patients: Sharkia Governorate, Egypt. Clin Lab 2011, 57(5-6):363-371.
32. Paavonen J., Naud P., Salmeron J., Wheeler C.M., Chow S.N., Apter D., et al. Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women. Lancet 2009, 374(9686):301-314.